About 200 reports

  • Products and services segmentation (2019)
  • Products and services segmentation (2019)

While there is not one factor that is known to cause these disorders, there are numerous measurable factors that can contribute to the development of these diseases. disorders.

  • Addiction Disorder
  • Mental Health
  • Pathology
  • Canada
  • Demand
  • 5.3 GLOBAL AND HISTORICAL TRENDS
  • 5.1 DISEASE BACKGROUND

The most common comorbidities associated with OUD are psychiatric disorders such as major depression, anxiety, and personality disorders.

  • Opioid
  • Pharmaceutical
  • Therapy
  • United States
  • Forecast
  • 3.4.2 Forecast Assumptions and Methods: 12-Month Total Prevalence of PTSD

PTSD, alcohol and drug use disorders, and selected mood, anxiety, and personality disorders were assessed using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-##.

  • Anxiety Disorder
  • Epidemiology
  • Mental Health
  • Pathology
  • Forecast
  • 4.2 CLASSIFICATION OR STAGING SYSTEMS
  • 7.5 CLEARER DIAGNOSTIC GUIDELINES

PTSD, alcohol and drug use disorders, and selected mood, anxiety, and personality disorders were assessed using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-##.

  • Anxiety Disorder
  • Mental Health
  • Pathology
  • Pharmaceutical
  • Therapy
  • KYOWA HAKKO KIRIN ENTERS INTO LICENSING AGREEMENT WITH SANDOZ

Therapy Area Cardiovascular Central Nervous System Dermatology Ear Nose Throat Disorders Gastrointestinal Genetic Disorders Genito Urinary System And Sex Hormones Hormonal Disorders Infectious Disease Musculoskeletal Oncology Respiratory Women' s Health Immunology No. of Deals

  • Biosimilar
  • Healthcare
  • Medical Biotechnology
  • Pharmaceutical
  • Sandoz Inc.
  • Clinical Trial profile. 168 Trial Title
  • 5. All the trials included are unique trials.

## ## ## ## ## ## ## ## China ## ## ## ## ## ## ## ## Russia ## ## ## ## ## ## ## ## Brazil ## ## ## ## ## ## ## ## Mexico ## ## ## ## ## ## ## ## Turkey Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are ta

  • Antipsychotic
  • Cardiovascular Drug
  • Clinical Trial
  • Neurology
  • Psychotic Disorder
  • PARTNERSHIPS

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Dermatological Condition
  • Healthcare
  • Pathology
  • Pharmaceutical
  • LEO Pharma A/S
  • CHEMOTHERAPY INDUCED NAUSEA AND VOMITING - PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H1 2019
  • CHEMOTHERAPY INDUCED NAUSEA AND VOMITING - PIPELINE BY HOVERINK BIOTECHNOLOGIES INC, H1 2019

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Chemotherapy
  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • Helsinn Group
  • GLOBAL PREMATURE EJACULATION TREATMENT MARKET BY SSRIS 2016-2021 ($ MILLIONS)
  • SSRIS

These drugs find applications in the treatment of anxiety, depression, and personality disorders.

  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • Eli Lilly & Co.
  • Hisamitsu Pharmaceutical and Kyowa Hakko Kirin Sign Commercialization Agreement for HP-3000

ONE UNIT REFERS TO ONE SPECIALTY BED.

  • Hospital
  • Mattress
  • Wound Care
  • East Asia
  • Japan
  • KYOWA HAKKO KIRIN ENTERS INTO LICENSING AGREEMENT WITH SANDOZ
  • KYOWA HAKKO KIRIN ENTERS INTO LICENSING AGREEMENT WITH SBI BIOTECH

Article ##.

  • Healthcare
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.
  • Clinical Trial profile. 35 Trial Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Clinical Trial
  • Mental Health
  • Psychotic Disorder
  • Therapy
  • Pfizer Inc.
  • 3.2 RISK FACTORS AND COMORBIDITIES
  • Risk Factors and Comorbid Conditions Associated with OUD

The most common comorbidities associated with OUD are psychiatric disorders such as major depression, anxiety, and personality disorders.

  • Epidemiology
  • Hospital
  • Opioid
  • United States
  • Forecast
  • ASSET PURCHASE

Rx PedPRM is to treat sleep disorders in children with autism spectrum disorders (ASD) and neurogenetic diseases.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • M&A
  • Aspen Pharmacare Holdings Limited
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H1 2018
  • PIPELINE BY COTINGA PHARMACEUTICALS INC, H1 2018

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Hospital
  • Oncology
  • Therapy
  • World
  • AstraZeneca PLC
  • ACTIVIOMICS ENTERS INTO RESEARCH AGREEMENT WITH KYOWA HAKKO
  • ACTIVIOMICS EXTENDS RESEARCH AGREEMENT WITH KYOWA HAKKO KIRIN

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Influenza
  • Pharmaceutical
  • United Kingdom
  • hVIVO plc
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2018
  • JOHNSON & JOHNSON

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • Product Initiative
  • Apexigen, Inc.
  • ORPEA SA: KEY FACTS
  • LEADING COMPANIES

Orpea' s psychiatric clinic facilities provide services for patients with acute mental pathologies, such as mood disorders, anxiety disorders, addiction, overuse or burnout syndromes, chronic fatigue syndrome, fibromyalgia, sleep disorders, eating disorders, b

  • Health Care Provider
  • Health Services
  • Healthcare
  • Western Europe
  • Market Size
  • FLX Bio Inc
  • Pipeline by FLX Bio Inc, H1 2018

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Protein Therapy
  • Therapy
  • United States
  • World
  • Kyowa Hakko Kirin Co., Ltd.
  • SANFORD HEALTH ACQUIRES HEMATECH, DRUG DEVELOPMENT COMPANY

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Health Services
  • Healthcare
  • Pharmaceutical
  • United States
  • Caladrius Biosciences, Inc.
  • BREXPIPRAZOLE - DRUG PROFILE

It is in Phase II stage of development for the treatment for borderline personality disorder.

  • Anxiety Disorder
  • Mental Health
  • Pharmaceutical
  • Therapy
  • Tonix Pharmaceuticals Holding Corp.
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017
  • PIPELINE BY TAKEDA PHARMACEUTICAL CO LTD, H2 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Digestive System Disorder
  • Therapy
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • FUJIFILM FORMS JOINT VENTURE WITH KYOWA HAKKO KIRIN

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • FUJIFILM Holdings Corporation
  • Description

Chapter ## provides an introduction to the report.

  • Therapy
  • United States
  • Demand
  • PARTNERSHIPS

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Japan
  • FUJIFILM Holdings Corporation
  • 11.2 ABBREVIATIONS
  • RISK FACTORS AND COMORBIDITIES FOR BED

DBT can be appropriate for patients suffering from borderline personality disorder (BPD), depression, bipolar disorder, and post-traumatic stress disorder (PTSD).

  • Eating Disorder
  • Mental Health
  • Pathology
  • Therapy
  • United States
  • PARTNERSHIPS

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Adimab LLC
  • PARTNERSHIPS

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Biotechnology
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Genmab group
  • KYOWA HAKKO KIRIN CO LTD
  • PIPELINE BY MEDIMMUNE LLC, H2 2018

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • United States
  • MedImmune, LLC
  • UNIPOLAR DEPRESSION

The others include disorders such as obsessive-compulsive disorder, post-traumatic stress disorder, personality disorder, Tourette syndrome, and autism.

  • Antipsychotic
  • Psychotic Disorder
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc